T Scientific Statistics

Total Valuation

T Scientific has a market cap or net worth of KRW 56.00 billion. The enterprise value is 51.65 billion.

Market Cap	56.00B
Enterprise Value	51.65B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

T Scientific has 71.25 million shares outstanding. The number of shares has decreased by -1.30% in one year.

Current Share Class	71.25M
Shares Outstanding	71.25M
Shares Change (YoY)	-1.30%
Shares Change (QoQ)	+22.92%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	0.22%
Float	47.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.41
PB Ratio	0.40
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.60, with an EV/FCF ratio of -10.74.

EV / Earnings	-112.40
EV / Sales	1.30
EV / EBITDA	32.60
EV / EBIT	134.81
EV / FCF	-10.74

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.04.

Current Ratio	2.26
Quick Ratio	1.84
Debt / Equity	0.04
Debt / EBITDA	3.21
Debt / FCF	-1.06
Interest Coverage	0.55

Financial Efficiency

Return on equity (ROE) is -0.09% and return on invested capital (ROIC) is 0.17%.

Return on Equity (ROE)	-0.09%
Return on Assets (ROA)	0.15%
Return on Invested Capital (ROIC)	0.17%
Return on Capital Employed (ROCE)	0.25%
Revenue Per Employee	566.92M
Profits Per Employee	-6.56M
Employee Count	70
Asset Turnover	0.25
Inventory Turnover	56.30

Taxes

Income Tax	-981.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.62% in the last 52 weeks. The beta is -0.39, so T Scientific's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-31.62%
50-Day Moving Average	988.00
200-Day Moving Average	1,039.46
Relative Strength Index (RSI)	31.54
Average Volume (20 Days)	196,666

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T Scientific had revenue of KRW 39.68 billion and -459.51 million in losses. Loss per share was -6.60.

Revenue	39.68B
Gross Profit	10.76B
Operating Income	383.13M
Pretax Income	-1.10B
Net Income	-459.51M
EBITDA	1.58B
EBIT	383.13M
Loss Per Share	-6.60

Full Income Statement

Balance Sheet

The company has 9.56 billion in cash and 5.09 billion in debt, giving a net cash position of 4.47 billion or 62.81 per share.

Cash & Cash Equivalents	9.56B
Total Debt	5.09B
Net Cash	4.47B
Net Cash Per Share	62.81
Equity (Book Value)	141.36B
Book Value Per Share	1,838.55
Working Capital	13.64B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.76 billion and capital expenditures -53.83 million, giving a free cash flow of -4.81 billion.

Operating Cash Flow	-4.76B
Capital Expenditures	-53.83M
Free Cash Flow	-4.81B
FCF Per Share	-67.50

Full Cash Flow Statement

Margins

Gross margin is 27.12%, with operating and profit margins of 0.97% and -1.16%.

Gross Margin	27.12%
Operating Margin	0.97%
Pretax Margin	-2.78%
Profit Margin	-1.16%
EBITDA Margin	3.99%
EBIT Margin	0.97%
FCF Margin	n/a

Dividends & Yields

T Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.30%
Shareholder Yield	1.30%
Earnings Yield	-0.82%
FCF Yield	-8.59%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

T Scientific has an Altman Z-Score of 2.03 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.03
Piotroski F-Score	4